Actively Recruiting
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
Led by Aventyn, Inc. · Updated on 2024-03-20
27000
Participants Needed
3
Research Sites
287 weeks
Total Duration
On this page
Sponsors
A
Aventyn, Inc.
Lead Sponsor
I
Intel Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are creating real-time epidemiology registry to evaluate the efficacy of COVID-19 subject risk assessment scores based on recording of symptoms, biomarkers, chronic illness and mental health assessments with digital technology using wearables and mobile app tools. Researchers aim to study in Phase 1, epidemiological variations in COVID-19 presentation in both PCR positive and negative subjects in the registry. Assessment of variables, predictive modeling of variables that impact severity of COVID-19 positive and negative subjects and assessment of predictors for post COVID-19 complications. In Phase 2, 2700 subjects with COVID-19 positive test will be studied in the intervention group comparing ECL-19 vs placebo with primary end point of hospital admission assessment. Treatment strategy for PCR positive COVID-19 subjects in the registry who are in Stage I of the disease process with ECL-19 drug compared to placebo in reducing hospital admissions
CONDITIONS
Official Title
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- COVID-19 PCR positive
- COVID-19 PCR negative
- COVID-19 PCR pending
- COVID-19 high risk score
You will not qualify if you...
- Unwillingness to participate before, during, or after consent
- Considered unreliable by investigator for follow-up visit requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Multiple Locations
Phoenix, Arizona, United States, 85016
Actively Recruiting
2
Multiple Locations
Bangalore, India
Actively Recruiting
3
Multiple Locations
Stockholm, Sweden
Actively Recruiting
Research Team
K
Kris Vijay, MD
CONTACT
N
Navin Govind
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here